Seelos Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Seelos Therapeutics, Inc.‘s stocks are currently a part of 68 hedge funds’ portfolios, which represents 24.1% of the total amount of its stocks outstanding. This makes up a total of 25.55M shares of Seelos Therapeutics, Inc.. Compared to the previous quarter, the number fell by -18.39% or -5.75M shares fewer. As for the holding position changes, 22.06% (15) of current hedge fund investors increased the number of shares held, 32.35% (22) of current holders sold a part of the shares held, and 10.29% (7) closed the holdings completely. 10 hedge funds are new holders of Seelos Therapeutics, Inc. stock in Q3 2022, it is 14.71% of total holders.
Hedge funds holding Seelos Therapeutics (Q4 2018 – Q3 2022)
| Q4 2018 | 1 |
|---|---|
| Q1 2019 | 12 |
| Q2 2019 | 15 |
| Q3 2019 | 20 |
| Q4 2019 | 14 |
| Q1 2020 | 21 |
| Q2 2020 | 26 |
| Q3 2020 | 24 |
| Q4 2020 | 26 |
| Q1 2021 | 68 |
| Q2 2021 | 97 |
| Q3 2021 | 104 |
| Q4 2021 | 90 |
| Q1 2022 | 83 |
| Q2 2022 | 72 |
| Q3 2022 | 68 |
Hedge funds changes in Seelos Therapeutics positions (Q4 2018 – Q3 2022)
| Q4 2018 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2019 | 11 | 1 | 0 | 0 | 0 |
| Q2 2019 | 8 | 6 | 1 | 5 | -5 |
| Q3 2019 | 8 | 6 | 2 | 3 | 1 |
| Q4 2019 | 2 | 5 | 4 | 8 | -5 |
| Q1 2020 | 9 | 6 | 2 | 1 | 3 |
| Q2 2020 | 10 | 5 | 5 | 5 | 1 |
| Q3 2020 | 7 | 6 | 5 | 9 | -3 |
| Q4 2020 | 11 | 7 | 4 | 8 | -4 |
| Q1 2021 | 48 | 12 | 7 | 6 | -5 |
| Q2 2021 | 48 | 25 | 17 | 19 | -12 |
| Q3 2021 | 24 | 38 | 25 | 16 | 1 |
| Q4 2021 | 11 | 35 | 22 | 24 | -2 |
| Q1 2022 | 13 | 26 | 27 | 20 | -3 |
| Q2 2022 | 17 | 19 | 24 | 24 | -12 |
| Q3 2022 | 10 | 15 | 22 | 7 | 14 |
Hedge funds changes in Seelos Therapeutics stock options (Q4 2018 – Q3 2022)
| Q4 2018 | 0 | 0 |
|---|---|---|
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 837,000 | 1,668,000 |
| Q2 2021 | 1,970,000 | 1,422,000 |
| Q3 2021 | 2,080,000 | 648,000 |
| Q4 2021 | 4,509,000 | 220,000 |
| Q1 2022 | 786,000 | 123,000 |
| Q2 2022 | 799,000 | 79,000 |
| Q3 2022 | 1,049,000 | 512,000 |